Skip to main content
. 2022 Jul 8;9:921016. doi: 10.3389/fmed.2022.921016

Table 7.

Results of treatment comparisons for postoperative 48 h.

A N = 1,−2.27 (−3.45;−1.09) N = 1,0.38 (−0.55;1.31)
0.12 (0.02,0.77) B N = 1,0.00 (−0.51;0.51)
0.80 (0.10,6.17) 6.51 (0.57,74.22) C N = 1,−0.80 (−1.32; −0.27)
0.12 (0.03,0.44) 1.00 (0.27,3.77) 0.15 (0.02,1.18) D N = 1,−1.88 (−2.98; −0.78)
0.71 (0.19,2.57) 5.76 (0.91,36.43) 0.88 (0.18,4.34) 5.76 (1.60,20.74) E N = 2,−0.64 (−0.98; −0.29) N = 2,−0.53 (−1.58;0.53) N = 1–0.34 (−0.84;0.16) N = 1,−0.34 (−0.84;0.16)
2.73 (0.54,13.80) 22.28 (2.76,179.75) 3.42 (0.53,22.14) 22.29 (4.45,111.72) 3.87 (1.45,10.29) F
1.81 (0.34,9.70) 14.72 (1.74,124.72) 2.26 (0.33,15.48) 14.73 (2.76,78.59) 2.56 (0.87,7.52) 0.66 (0.15,2.83) G
0.80 (0.08,8.00) 6.51 (0.46,92.69) 1.00 (0.16,6.17) 6.52 (0.65,64.99) 1.13 (0.17,7.65) 0.29 (0.03,2.50) 0.44 (0.05,3.99) H N = 1,−0.93 (−1.53; −0.33)
1.96 (0.22,17.14) 16.01 (1.27,202.40) 2.46 (0.48,12.67) 16.01 (1.84,139.19) 2.78 (0.49,15.89) 0.72 (0.10,5.31) 1.09 (0.14,8.47) 2.46 (0.35,17.34) I N = 1,−0.94 (−1.47; −0.40)
0.44 (0.08,2.55) 3.57 (0.40,32.22) 0.55 (0.19,1.56) 3.57 (0.62,20.64) 0.62 (0.19,2.06) 0.16 (0.03,0.75) 0.24 (0.05,1.22) 0.55 (0.12,2.43) 0.22 (0.06,0.79) J N = 1,0.03 (−0.59;0.65) N = 1,0.18 (−0.54;0.90)
1.29 (0.19,8.54) 10.50 (1.05,105.29) 1.61 (0.20,13.27) 10.50 (1.59,69.19) 1.82 (0.46,7.27) 0.47 (0.09,2.57) 0.71 (0.12,4.12) 1.61 (0.15,17.07) 0.66 (0.07,6.07) 2.94 (0.47,18.35) K
0.42 (0.04,4.32) 3.40 (0.23,49.82) 0.52 (0.08,3.35) 3.40 (0.33,35.09) 0.59 (0.08,4.16) 0.15 (0.02,1.36) 0.23 (0.02,2.15) 0.52 (0.06,4.45) 0.21 (0.03,1.56) 0.95 (0.20,4.44) 0.32 (0.03,3.55) L
0.40 (0.05,3.07) 3.23 (0.28,36.93) 0.50 (0.11,2.18) 3.24 (0.42,24.93) 0.56 (0.11,2.76) 0.15 (0.02,0.94) 0.22 (0.03,1.51) 0.50 (0.17,1.43) 0.20 (0.04,1.04) 0.91 (0.32,2.58) 0.31 (0.04,2.54) 0.95 (0.15,6.13) M N = 1,−0.38 (−0.99;0.23)
0.65 (0.06,7.19) 5.33 (0.35,82.37) 0.82 (0.12,5.68) 5.33 (0.49,58.46) 0.93 (0.12,7.01) 0.24 (0.03,2.27) 0.36 (0.04,3.60) 0.82 (0.16,4.22) 0.33 (0.04,2.62) 1.49 (0.29,7.63) 0.51 (0.04,5.90) 1.57 (0.17,14.80) 1.65 (0.47,5.76) N

1. Lower-left triangle presents the findings (MD with 95%CI) of the network meta-analysis conducted using Stata 15.1. Upper-right triangle presents the findings (SMD with 95% CI) of the pair-wise meta-analyses conducted using STATA 15.1 and N refers to the numbers of RCTs which compared the 2 interventions directly. 3. A positive MD favors the lower-right intervention; a negative MD favors the upper-left intervention. 4. Statistically significant findings are shaded. A, CEB (cervical epidural block); B, EA (external application); C, HTESPB (high thoracic erector spinae plane block); D, IAI (intra-articular injection); E, INB (interscalene nerve block); F, INB+IAI (interscalene nerve block + intra-articular injection); G, INB+IVA (interscalene nerve block + intravenous administration); H, INB+SSNB (interscalene nerve block + suprascapular nerve block); I, OA (oral administration); J, PL (placebo); K, SCNB (supraclavicular nerve block); L, SGB (stellate ganglion block); M, SSNB (suprascapular nerve block); N, SSNB+ANB (suprascapular nerve block + axillary nerve block).

Red represents the code of intervention measures and green represents the significant difference between two intervention measures with statistical significance.